With a market value of $30.1 billion, Cognizant Technology Solutions Corporation (CTSH) is a professional services company that provides consulting, technology, and outsourcing services. The Teaneck, New Jersey-based company specializes in helping global enterprises modernize their technology infrastructure, improve business processes, and improve customer experiences in the financial services, healthcare, and retail sectors.
Companies valued at $10 billion or more are generally classified as “large-cap stocks,” and CTSH fits the label perfectly, with a market cap above that range, indicating its size, influence, and dominance in the IT services industry. Leveraging a large global workforce, the company employs an AI-led transformation strategy, using proprietary platforms such as Neuro AI to integrate productive AI and agentic systems into enterprise operations to drive efficiency and innovation.
The tech company is down 26.8% from its 52-week high of $87.03 reached on January 14. Shares of CTSH have fallen 23.8% over the past three months, with the Dow Jones Industrial Average ($DOWI) down 2.2% over the same time frame.
Furthermore, on a YTD basis, CTSH shares are down 23% compared to the DOWI’s slight decline. In the longer term, CTSH has fallen 22.5% over the past 52 weeks, trailing DOWI’s 15% rise over the same time frame.
Confirming its price trend, CTSH has been trading below its 200-day and 50-day moving averages since early February.
On February 4, CTSH shares rose 3% after it delivered better-than-expected Q4 earnings results. The company’s total revenue rose 4.9% year-over-year to $5.3 billion, narrowly missing consensus estimates. Additionally, its adjusted EPS grew 11.6% to $1.35 from last year’s quarter, beating analyst expectations of $1.32. The company has invested in strengthening its partnership ecosystem and advanced its AI platforms to help customers scale AI across the enterprise. This investment helped CTSH sign 28 major deals by 2025, growing major deal TCV by nearly 50% year-on-year.
CTSH outperformed its rival, Accenture plc (ACN), which has declined 38.1% over the past 52 weeks and 24.3% on a YTD basis.
